Skip to main content
logo
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China flag China · Delayed Price · Currency is CNY
22.50
-0.32 (-1.40%)
Sep 11, 2026, 3:04 PM CST

SHE:300255 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
859.35875.131,0311,4102,3362,968
Revenue Growth
-9.98%-15.10%-26.92%-39.63%-21.29%25.56%
Gross Profit
40.4120.8693.46-322.771,0211,722
Operating Income
-218.24-236.07-178.78-1,145107.99324.06
Net Income
-345.57-357.9-249.48-1,24017.51233.57
Earnings Per Share
-0.41-0.39-0.27-1.350.020.25
EPS Growth
-----92.00%-7.41%

Revenue by Segment
Chart
Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Biopharmaceutical
753.08896.441,2752,2732,889
Others
122.05134.37135.7763.3279.01
Total
875.131,0311,4102,3362,968

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
180.25128236.44230.92797.8543.21
Total Debt
2,8002,5652,5422,3672,4901,739
Net Cash (Debt)
-2,620-2,437-2,305-2,136-1,692-1,195
Net Cash Growth
------
Net Cash Per Share
-3.08-2.66-2.49-2.32-1.93-1.28

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
-96.9355.6856.2233.733.132.87
Capital Expenditures
-143.12-123.36-239.59-239.32-431.22-308.08
Free Cash Flow
-240.05-67.68-183.37-205.6-428.1-305.21
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
4.70%2.38%9.07%-22.88%43.71%58.01%
Operating Margin
-25.40%-26.98%-17.34%-81.17%4.62%10.92%
Pretax Margin
-39.79%-40.67%-24.94%-87.33%0.78%8.77%
Profit Margin
-40.21%-40.90%-24.20%-87.93%0.75%7.87%
FCF Margin
-27.93%-7.73%-17.79%-14.58%-18.32%-10.28%

Dividends
Chart
Fiscal YearFY 2022FY 2021
Period EndingJan '23 Jan '22
Dividend Per Share
0.0050.026
Dividend Per Share Growth
-80.77%-
Dividend Yield
0.09%0.32%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
----287.5831.99
Forward PE
-12.4412.4412.4412.4412.44
PS Ratio
24.0665.2217.828.482.162.52